Clinical Trial Update: Vaccine Therapy Plus Sargramostim and Chemotherapy in Treating Women With Stage II or Stage III Breast Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating a vaccine therapy with sargramostim and chemotherapy in women with Stage II/III breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Chemotherapy (unspecified regimen)
• Vaccine therapy
• sargramostim (sargramostim)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED